Metraipolis › archive › dc_a5caa11adfd7
Osteopontin-4 (OPN-4) Suppresses Tumor Progression Features Whilst Sensitizing c643 Anaplastic Thyroid Cells to Sorafenib — Europe PMC PMID:42193316
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42193316
- DOI
- 10.3390/biomedicines14050989
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T06:33:20.675Z
- SHA-256 of the archived text
2011bfe84e8049b5c295c6ba131ae1d13d3fed7d07413b3cca1b42ae3afeb6e2- Stable URL of this page
https://metraipolis.com/documento/dc_a5caa11adfd7
How to cite
Osteopontin-4 (OPN-4) Suppresses Tumor Progression Features Whilst Sensitizing c643 Anaplastic Thyroid Cells to Sorafenib — Europe PMC PMID:42193316 — Europe PMC (en), https://europepmc.org/article/MED/42193316 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5caa11adfd7 (Metraipolis archive dc_a5caa11adfd7, sha256 2011bfe84e8049b5c295c6ba131ae1d13d3fed7d07413b3cca1b42ae3afeb6e2)
BibTeX
@misc{dca5caa11adfd7,
title = {Osteopontin-4 (OPN-4) Suppresses Tumor Progression Features Whilst Sensitizing c643 Anaplastic Thyroid Cells to Sorafenib — Europe PMC PMID:42193316},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42193316},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5caa11adfd7; sha256 2011bfe84e8049b5c295c6ba131ae1d13d3fed7d07413b3cca1b42ae3afeb6e2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42193316. Agents can read the archived copy with the MCP tool read_document.